Author(s): Manisha P. Puranik, Debarshi Kar Mahapatra, Rutuja M. Telang, Swadesh Kumar Pattanik

Email(s): manisha68_12@yahoo.com

DOI: 10.52711/0974-360X.2026.00683   

Address: Manisha P. Puranik1*, Debarshi Kar Mahapatra2, Rutuja M. Telang1, Swadesh Kumar Pattanik2
1Department of Quality Assurance, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha 442001, Maharashtra, India.
2Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
*Corresponding Author

Published In:   Volume - 19,      Issue - 10,     Year - 2026


ABSTRACT:
This work attempted to debunk the common belief that commercially available honey brands in India have sucrose content above the permitted level of 5% as per Food Safety and Standards Authority of India (FSSAI) guidelines and to authenticate and analyze the possibility of adulteration in selected Indian honey brand samples through comparative sugar profiling using High Performance Thin Layer Chromatography (HPTLC). In total, six Indian honey brand samples (H1 to H6) were analyzed under physicochemical analysis and purity tests to check the presence of reducing sugars, artificial sugars, starch, dextrin, azo dyes, chloride, sulphate, along with other parameters such as specific gravity, ash value, and pH. A novel HPTLC method for quantitative estimation of fructose, glucose, sucrose, and maltose using multilevel calibration curves was developed. All samples passed qualitative tests for purity and adulteration. Crucially, the absence or presence in trace amount of sucrose (maximum 1.441% in H2) proved that none of the samples had sucrose content beyond the permitted 5% limit and thus busted the myth that honey brands in India are adulterated above the FSSAI limit. Nonetheless, sugar profiling using HPTLC showed that three samples (H3 and H4) was deficient in total reducing sugars content (minimum required level- 65%). Furthermore, fructose to glucose ratios for all the samples were less than 0.95 and indicated probable adulteration with glucose or invert syrup. Glucose content in samples ranged from 45.92 to 68.60%, whereas fructose ranged from 31.32 to 52.36%. Maltose was either not detected or present in traces (=0.347%). All the calibration curves showed good linearity with R² >0.99 and coefficient of variations of 2–5%. While it was confirmed that sucrose levels in Indian honey samples did not cross the limit, yet another form of adulteration, that is, a low fructose to glucose ratio and inadequate reducing sugar content, was identified.


Cite this article:
Manisha P. Puranik, Debarshi Kar Mahapatra, Rutuja M. Telang, Swadesh Kumar Pattanik. Myth Busted Successfully - Indian Honey Brands do not contain Sucrose above FSSAI Limit: A HPTLC-based Comparative Sugar Profiling Study. Research Journal Pharmacy and Technology. 2026;19(10):4901-8. doi: 10.52711/0974-360X.2026.00683

Cite(Electronic):
Manisha P. Puranik, Debarshi Kar Mahapatra, Rutuja M. Telang, Swadesh Kumar Pattanik. Myth Busted Successfully - Indian Honey Brands do not contain Sucrose above FSSAI Limit: A HPTLC-based Comparative Sugar Profiling Study. Research Journal Pharmacy and Technology. 2026;19(10):4901-8. doi: 10.52711/0974-360X.2026.00683   Available on: https://rjptonline.org/AbstractView.aspx?PID=2026-19-10-59


REFERENCES:
1.    Mohamed SH, Elshahed MM, Saied YM. Evaluation of Honey as an antibacterial agent against drug-resistant uropathogenic E. coli strains. Res J Pharm Technol. 2020; 13(8): 3720-4.
2.    Muda TF, Ismail ZI, Abdullah S, Simbak NB, Haque M. The Effects of Honey on Inflammatory Cells in Cigarette Smoke Affected Lungs in Rats: A Preliminary Study. Res J Pharm Technol. 2014; 7(12): 1382-6.
3.    Gupta PK, Narayan C, Shah K, Kumar A, Singh BM. In vitro analysis of synergistic effect of honey against chemically induced hepatic insult in Balb/c mice. Res J Pharm Technol. 2021; 14(12): 6309-14.
4.    Bhushanam M, Reddy MS. Physico-chemical and antibacterial characteristics of Apis honeys from Karnataka, India. Res J Pharm Technol. 2012; 5(1): 95-7.
5.    Qaid HR, Aljunaid MA, Kaid N, Ridwan RD, Budi HS, Kusumaningrum D, Syifa S, Alaghbari SG. Antibacterial Activity of Sidr Honey against Periodontopathogen Bacteria: As In vitro Study Antibacterial of Sidr Honey. Res J Pharm Technol. 2025; 18(4): 1789-94.
6.    Ahmed SH. Bioactivity of Fortified Honey with lycopene extracted from tomatoes Solanum lycopersicum. Res J Pharm Technol. 2021; 14(10): 5115-20.
7.    Food Safety and Standards Authority of India (FSSAI). Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011. New Delhi: FSSAI; 2011.
8.    Codex Alimentarius Commission. Revised Codex Standard for Honey. CODEX STAN 12 1981. Rome: FAO/WHO; 2001.
9.    Wulansari DD, Kirtishanti A, Wulandari DD. Potential effect of Raw Honey on Gastric Mucosal Healing in Aspirin-induced Rats. Res J Pharm Technol. 2023; 16(3): 1153-60.
10.    Aishwarya SS, Gowri V, Chellathai DD. Honey a therapeutic trial in osteosarcoma. Res J Pharm Technol. 2019; 12(6): 2959-62.
11.    Moholkar SA, Mukherjee-Kandhare AA, Worlikar PS, Tilak A. Synergistic Potential of Honey and Shatdhaut Ghrut in the management of Diabetic Foot Ulcer in the Experimental rats. Res J Pharm Technol. 2020; 13(3): 1377-85.
12.    Al-Ghazali MA, Abu-Khader M, Attia RA, Al-Tahan MA, Aqrawi MS. Knowledge and awareness of the therapeutic benefits and precautions of natural honey consumption among students. Res J Pharm Technol. 2023; 16(10): 4911-6.
13.    Jebaraj SA, Gopinath P. Antibacterial Activity of Honey Against Clinical Isolates of Pseudomonas aeruginosa. Res J Pharm Technol. 2016; 9(8): 1174-6.
14.    Dhabarde DM, Shahare HV, Gedam SS, Bhoyar PK, Ganjiwale RO. Aging of honey enhances its antibacterial activity. Res J Pharm Technol. 2009; 2(4): 876-7.
15.    Puranik PM, Mahapatra DK, Tiple DS, Zade GP. ICH-Compliant HPTLC Method for the Quantitative Determination of Sacubitril and Valsartan in Pharmaceutical Tablets. Res J Pharm Technol. 2025; 18(11): 5395-400.
16.    Puranik M, Mahapatra DK, Bhoyar HS. Stability-Indicating HPTLC Method for the Determination of Febuxostat in Bulk and Pharmaceutical Formulation. J Med Pharm Allied Sci. 2022; 11(3): 4817-23.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.52711/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available